Thymalin
Thymus polypeptide extract used in Russian/CIS clinics for immune support; sister product to Thymosin.
Scientific Overview
Thymalin is a polypeptide extract from calf thymus developed by Khavinson and colleagues in the 1970s and registered in Russia for immunodeficiency states. Russian clinical studies report T-cell normalization in elderly patients and improvements in chronic-infection outcomes. Western peer-reviewed RCTs are sparse; evidence is dominated by Russian groups.
Key Research Benefits
- ✓Immune modulation
- ✓Adjunct in chronic infection (Russia)
- ✓Reported gerontoprotective effect
Potential Side Effects
Research Protocols
Common DosagesImmune (Russia)
“Per Russian protocols”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 4.00 mL on a U-100 syringe
Explore Thymalin
Where to source
Vendors with public COAs that stock this category. Affiliate links are disclosed.
- Limitless Life NootropicsFL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.COA: JanoshikAffiliate disclosed
- SwissChems60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.COA: JanoshikAffiliate disclosed
- Amino ClubEU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.COA: Third-partyAffiliate disclosed
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Other
- Common Dosage
- 5-20 mg
- Daily IM, 5-10 day cycles
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.